Skip to Content

Sangamo Therapeutics Inc SGMO

Morningstar Rating
$1.13 +0.03 (2.73%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

SGMO is trading at a 48% discount.
Price
$1.13
Fair Value
$9.45
Uncertainty
Extreme
1-Star Price
$2.82
5-Star Price
$2.69
Economic Moat
Cfdxq
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if SGMO is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$1.10
Day Range
$1.051.21
52-Week Range
$0.293.16
Bid/Ask
$1.12 / $1.15
Market Cap
$200.40 Mil
Volume/Avg
2.3 Mil / 2.2 Mil

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.64
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.
Sector
Healthcare
Industry
Biotechnology
Stock Style Box
Small Value
Total Number of Employees
478

Comparables

Valuation

Metric
SGMO
NTLA
AVIR
Price/Earnings (Normalized)
Price/Book Value
0.992.430.58
Price/Sales
0.6447.24
Price/Cash Flow
Price/Earnings
SGMO
NTLA
AVIR

Financial Strength

Metric
SGMO
NTLA
AVIR
Quick Ratio
2.768.2331.50
Current Ratio
3.048.6731.93
Interest Coverage
Quick Ratio
SGMO
NTLA
AVIR

Profitability

Metric
SGMO
NTLA
AVIR
Return on Assets (Normalized)
−15.64%−25.49%−14.35%
Return on Equity (Normalized)
−25.60%−30.88%−14.90%
Return on Invested Capital (Normalized)
−26.67%−31.84%−18.26%
Return on Assets
SGMO
NTLA
AVIR
See how this stock stacks up to its competitors with Morningstar Investor

Biotechnology Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
NVO
Novo Nordisk A/S ADRKzkms$550.2 Bil
VRTX
Vertex Pharmaceuticals IncLrdlxh$111.1 Bil
REGN
Regeneron Pharmaceuticals IncVlzqy$107.6 Bil
MRNA
Moderna IncShn$36.8 Bil
ARGX
argenx SE ADRFpng$24.2 Bil
BNTX
BioNTech SE ADRNjxr$22.4 Bil
ALNY
Alnylam Pharmaceuticals IncDfyhvpx$19.9 Bil
BMRN
Biomarin Pharmaceutical IncPgcjks$17.2 Bil
RPRX
Royalty Pharma PLC Class ABqnfmj$13.9 Bil
INCY
Incyte CorpPpprx$13.6 Bil

Sponsor Center